Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Ana Kerguelen Fuentes"'
Autor:
Maria Eva Mingot-Castellano, Rosa Goterris, Moraima Jiménez, Valle Recasens, Saioa Zalba, Marta Fernandez-Docampo, Ana Kerguelen Fuentes, Jose Garcia-Arroba, Inés Gómez-Seguí, David Valcárcel, Cristina Pascual Izquierdo
Publikováno v:
Blood. 140:5011-5012
Autor:
Holly L. Geyer, Heidi Kosiorek, Amylou C. Dueck, Robyn Scherber, Stefanie Slot, Sonja Zweegman, Peter AW te Boekhorst, Zhenya Senyak, Harry C. Schouten, Federico Sackmann, Ana Kerguelen Fuentes, Dolores Hernández-Maraver, Heike L. Pahl, Martin Griesshammer, Frank Stegelmann, Konstanze Döhner, Thomas Lehmann, Karin Bonatz, Andreas Reiter, Francoise Boyer, Gabriel Etienne, Jean-Christophe Ianotto, Dana Ranta, Lydia Roy, Jean-Yves Cahn, Claire N. Harrison, Deepti Radia, Pablo Muxi, Norman Maldonado, Carlos Besses, Francisco Cervantes, Peter L. Johansson, Tiziano Barbui, Giovanni Barosi, Alessandro M. Vannucchi, Chiara Paoli, Francesco Passamonti, Bjorn Andreasson, Maria L Ferrari, Alessandro Rambaldi, Jan Samuelsson, Keith Cannon, Gunnar Birgegard, Zhijian Xiao, Zefeng Xu, Yue Zhang, Xiujuan Sun, Junqing Xu, Jean-Jacques Kiladjian, Peihong Zhang, Robert Peter Gale, Ruben A. Mesa
Publikováno v:
Haematologica, Vol 102, Iss 1 (2017)
The myeloproliferative neoplasms, including polycythemia vera, essential thrombocythemia and myelofibrosis, are distinguished by their debilitating symptom profiles, life-threatening complications and profound impact on quality of life. The role gend
Externí odkaz:
https://doaj.org/article/b8f3bfa30986447c9692146db10cad5d
Autor:
Robyn M. Scherber, Claire N. Harrison, Ruben A. Mesa, Stefanie Slot, Junqing Xu, Jean-Jacques Kiladjian, Zefeng Xu, Pablo J. Muxi, Chiara Paoli, Harry C. Schouten, Lydia Roy, Peter A. W. te Boekhorst, Robert Peter Gale, Norman Maldonado, Thomas Lehmann, Karin Bonatz, Maria Luisa Ferrari, Federico Sackmann, Jean Christophe Ianotto, Peihong Zhang, Giovanni Barosi, Alessandro Rambaldi, Bjorn Andreasson, Peter L. Johansson, Xiujuan Sun, Allison H. Scotch, Ana Kerguelen Fuentes, Jean-Yves Cahn, Deepti Radia, Suzan Commandeur, Zhijian Xiao, Jan Samuelsson, Heidi E. Kosiorek, Francisco Cervantes, Yue Zhang, Gabriel Etienne, Heike L. Pahl, Françoise Boyer, Martin Griesshammer, Francesco Passamonti, Konstanze Döhner, Gunnar Birgegård, Sonja Zweegman, Carlos Besses, Alessandro M. Vannucchi, Dana Ranta, Frank Stegelmann, Dolores Hernández-Maraver, Amylou C. Dueck, Holly L. Geyer, Tiziano Barbui, Andreas Reiter
Publikováno v:
Leukemia Research, 63, 34-40. Elsevier Ltd.
Scotch, A H, Kosiorek, H, Scherber, R, Dueck, A C, Slot, S, Zweegman, S, Boekhorst, P A W T, Commandeur, S, Schouten, H, Sackmann, F, Fuentes, A K, Hernández-Maraver, D, Pahl, H L, Griesshammer, M, Stegelmann, F, Döhner, K, Lehmann, T, Bonatz, K, Reiter, A, Boyer, F, Etienne, G, Ianotto, J C, Ranta, D, Roy, L, Cahn, J Y, Harrison, C N, Radia, D, Muxi, P, Maldonado, N, Besses, C, Cervantes, F, Johansson, P L, Barbui, T, Barosi, G, Vannucchi, A M, Paoli, C, Passamonti, F, Andreasson, B, Ferrari, M L, Rambaldi, A, Samuelsson, J, Birgegard, G, Xiao, Z, Xu, Z, Zhang, Y, Sun, X, Xu, J, Kiladjian, J J, Zhang, P, Gale, R P, Mesa, R A & Geyer, H L 2017, ' Symptom burden profile in myelofibrosis patients with thrombocytopenia : Lessons and unmet needs ', Leukemia Research, vol. 63, pp. 34-40 . https://doi.org/10.1016/j.leukres.2017.10.002
Leukemia Research, 63, 34-40. Elsevier Limited
Leuk Res
Scotch, A H, Kosiorek, H, Scherber, R, Dueck, A C, Slot, S, Zweegman, S, Boekhorst, P A W T, Commandeur, S, Schouten, H, Sackmann, F, Fuentes, A K, Hernández-Maraver, D, Pahl, H L, Griesshammer, M, Stegelmann, F, Döhner, K, Lehmann, T, Bonatz, K, Reiter, A, Boyer, F, Etienne, G, Ianotto, J C, Ranta, D, Roy, L, Cahn, J Y, Harrison, C N, Radia, D, Muxi, P, Maldonado, N, Besses, C, Cervantes, F, Johansson, P L, Barbui, T, Barosi, G, Vannucchi, A M, Paoli, C, Passamonti, F, Andreasson, B, Ferrari, M L, Rambaldi, A, Samuelsson, J, Birgegard, G, Xiao, Z, Xu, Z, Zhang, Y, Sun, X, Xu, J, Kiladjian, J J, Zhang, P, Gale, R P, Mesa, R A & Geyer, H L 2017, ' Symptom burden profile in myelofibrosis patients with thrombocytopenia : Lessons and unmet needs ', Leukemia Research, vol. 63, pp. 34-40 . https://doi.org/10.1016/j.leukres.2017.10.002
Leukemia Research, 63, 34-40. Elsevier Limited
Leuk Res
Myelofibrosis is a myeloproliferative neoplasm associated with progressive cytopenias and high symptom burden. MF patients with thrombocytopenia have poor prognosis but the presence of thrombocytopenia frequently precludes the use of JAK2 inhibitors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::022b1a49d48b9e484baa96dcb56756c9
http://hdl.handle.net/11383/2066806
http://hdl.handle.net/11383/2066806
Autor:
Jose Valentín García Gutiérrez, Carles Besses, Jesús María Hernández-Rivas, Patricia Velez, Rosa Ayala, María Teresa Gómez-Casares, Constantino Martínez, Lurdes Zamora, Beatriz Arrizabalaga, Ana Belen F Arroyo, Elisa Luño, Ana Kerguelen Fuentes, Concepción Boqué, D. Fiallo, Juan Carlos Hernandez Boluda, Vicente Vicente, Francisca Ferrer Marin, Carmen Garcia-Hernandez, Alberto Alvarez-Larrán, Raul Teruel Montoya, Rocío González-Conejero, Beatriz Bellosillo
Publikováno v:
Blood. 132:3072-3072
Introduction: Transformation to secondary myelofibrosis (MF) occurs as part of the natural history of polycythemia vera (PV) and essential thrombocythemia (ET), the two more indolent Ph-negative myeloproliferative neoplasms (MPN). Once transformed, s
Autor:
Elisabeth Ejerblad, Catherine Cargo, Holly L. Geyer, Jonathan O. Cullis, Mary Frances McMullin, Robyn M. Scherber, Joanne Ewing, Marlene Girardo, Bjorn Andreasson, Peter L. Johansson, Federico Sackman, Amylou C. Dueck, Gunnar Birgegård, Frances Wadelin, Heidi E. Kosiorek, Ruben A. Mesa, Mallika Sekhar, Jan J. Michiels, Wunna Swe, Alessandro M. Vannucchi, Jean-Loup Demory, Christen Lykkegaard Andersen, Veena Fauble, Satareh Shekouhi, Ana Kerguelen Fuentes, Nigel Sargant, Constantine S. Tam, David M. Ross, Paul Moreton, Allison Gathany, Robert N Lown, Deepti Radia
Publikováno v:
Blood. 132:1762-1762
Background: Myeloproliferative neoplasms (MPN) including polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF) are clonal hemopathies characterized by burdensome symptom profiles and impaired quality of life. Treatments inclu
Autor:
Peihong Zhang, Giovanni Barosi, Zefeng Xu, Alessandro M. Vannucchi, Chiara Paoli, Carlos Besses, Bjorn Andreasson, Peter L. Johansson, Peter A. W. te Boekhorst, Xiujuan Sun, Jan Samuelsson, Gunnar Birgegård, Yue Zhang, Ana Kerguelen Fuentes, Dana Ranta, Ruben A. Mesa, Keith Cannon, Dolores Hernández-Maraver, Andreas Reiter, Robyn M. Scherber, Jean-Yves Cahn, Amylou C. Dueck, Heike L. Pahl, Lydia Roy, Karin Bonatz, Pablo J. Muxi, Zhenya Senyak, Jean-Jacques Kiladjian, Gabriel Etienne, Holly L. Geyer, Stefanie Slot, Robert Peter Gale, Claire N. Harrison, Frank Stegelmann, Federico Sackmann, Francesco Passamonti, Jean Christophe Ianotto, Heidi E. Kosiorek, Martin Griesshammer, Harry C. Schouten, Sonja Zweegman, Norman Maldonado, Maria Luisa Ferrari, Alessandro Rambaldi, Francisco Cervantes, Deepti Radia, Konstanze Döhner, Zhijian Xiao, Tiziano Barbui, Thomas Lehmann, Françoise Boyer, Junqing Xu
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Haematologica, 102(1), 85-93. Ferrata Storti Foundation
Haematologica-the Hematology Journal, 102(1), 85-93. Ferrata Storti Foundation
Geyer, H L, Kosiorek, H, Dueck, A C, Scherber, R, Slot, S, Zweegman, S, Te Boekhorst, P A, Senyak, Z, Schouten, H C, Sackmann, F, Fuentes, A K, Hernández-Maraver, D, Pahl, H L, Griesshammer, M, Stegelmann, F, Döhner, K, Lehmann, T, Bonatz, K, Reiter, A, Boyer, F, Etienne, G, Ianotto, J-C, Ranta, D, Roy, L, Cahn, J-Y, Harrison, C N, Radia, D, Muxi, P, Maldonado, N, Besses, C, Cervantes, F, Johansson, P L, Barbui, T, Barosi, G, Vannucchi, A M, Paoli, C, Passamonti, F, Andreasson, B, Ferrari, M L, Rambaldi, A, Samuelsson, J, Cannon, K, Birgegard, G, Xiao, Z, Xu, Z, Zhang, Y, Sun, X, Xu, J, Kiladjian, J-J, Zhang, P, Gale, R P & Mesa, R A 2017, ' Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms : an analysis by the MPN QOL International Working Group ', Haematologica, vol. 102, no. 1, pp. 85-93 . https://doi.org/10.3324/haematol.2016.149559
Consejería de Sanidad de la Comunidad de Madrid
Haematologica, 102(1), 85-93. Ferrata Storti Foundation
Haematologica-the Hematology Journal, 102(1), 85-93. Ferrata Storti Foundation
Geyer, H L, Kosiorek, H, Dueck, A C, Scherber, R, Slot, S, Zweegman, S, Te Boekhorst, P A, Senyak, Z, Schouten, H C, Sackmann, F, Fuentes, A K, Hernández-Maraver, D, Pahl, H L, Griesshammer, M, Stegelmann, F, Döhner, K, Lehmann, T, Bonatz, K, Reiter, A, Boyer, F, Etienne, G, Ianotto, J-C, Ranta, D, Roy, L, Cahn, J-Y, Harrison, C N, Radia, D, Muxi, P, Maldonado, N, Besses, C, Cervantes, F, Johansson, P L, Barbui, T, Barosi, G, Vannucchi, A M, Paoli, C, Passamonti, F, Andreasson, B, Ferrari, M L, Rambaldi, A, Samuelsson, J, Cannon, K, Birgegard, G, Xiao, Z, Xu, Z, Zhang, Y, Sun, X, Xu, J, Kiladjian, J-J, Zhang, P, Gale, R P & Mesa, R A 2017, ' Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms : an analysis by the MPN QOL International Working Group ', Haematologica, vol. 102, no. 1, pp. 85-93 . https://doi.org/10.3324/haematol.2016.149559
The myeloproliferative neoplasms, including polycythemia vera, essential thrombocythemia and myelofibrosis, are distinguished by their debilitating symptom profiles, life-threatening complications and profound impact on quality of life. The role gend
Autor:
Bjorn Andreasson, Peter L. Johansson, Federico Sackmann, Giovanni Barosi, Zhijian Xiao, Françoise Boyer, Ruben A. Mesa, Suzan Commandeur, Carlos Besses, Tiziano Barbui, Norman Maldonado, Maria Luisa Ferrari, Peter A. W. te Boekhorst, Francisco Cervantes, Jean-Jacques Kiladjian, Yue Zhang, Zhenya Senyak, Harry C. Schouten, Karin Bonatz, Konstanze Döhner, Dana Ranta, Zefeng Xu, Jan Samuelsson, Jean-Yves Cahn, Francesco Passamonti, Deepti Radia, Andreas Reiter, Sonja Zweegman, Xiujuan Sun, Alessandro Rambaldi, Ana Kerguelen Fuentes, Junqing Xu, Thomas Lehmann, Lydia Roy, Gabriel Etienne, Alessandro M. Vannucchi, Heidi E. Kosiorek, Jean Christophe Ianotto, Martin Griesshammer, Peihong Zhang, Robert Peter Gale, Heike L. Pahl, Gunnar Birgegård, Claire N. Harrison, Frank Stegelmann, Robyn M. Scherber, Pablo J. Muxi, Stefanie Slot, Dolores Hernández-Maraver, Amylou C. Dueck, Holly L. Geyer
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, 2016, 34 (2), pp.151-9. ⟨10.1200/JCO.2015.62.9337⟩
Geyer, H, Scherber, R, Kosiorek, H, Dueck, A C, Kiladjian, J-J, Xiao, Z, Slot, S, Zweegman, S, Sackmann, F, Kerguelen Fuentes, A, Hernandez-Maraver, D, Doehner, K, Harrison, C N, Radia, D, Muxi, P, Besses, C, Cervantes, F, Johansson, P L, Andreasson, B, Rambaldi, A, Barbui, T, Bonatz, K, Reiter, A, Boyer, F, Etienne, G, Ianotto, J-C, Ranta, D, Roy, L, Cahn, J-Y, Maldonado, N, Barosi, G, Ferrari, M L, Gale, R P, Birgegard, G, Xu, Z, Zhang, Y, Sun, X, Xu, J, Zhang, P, te Boekhorst, P A W, Commandeur, S, Schouten, H, Pahl, H L, Griesshammer, M, Stegelmann, F, Lehmann, T, Senyak, Z, Vannucchi, A M, Passamonti, F, Samuelsson, J & Mesa, R A 2016, ' Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease ', Journal of Clinical Oncology, vol. 34, no. 2, pp. 151-+ . https://doi.org/10.1200/JCO.2015.62.9337
Journal of Clinical Oncology, 34(2), 151-+. American Society of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2016, 34 (2), pp.151-9. ⟨10.1200/JCO.2015.62.9337⟩
Journal of Clinical Oncology, 2016, 34 (2), pp.151-9. ⟨10.1200/JCO.2015.62.9337⟩
Geyer, H, Scherber, R, Kosiorek, H, Dueck, A C, Kiladjian, J-J, Xiao, Z, Slot, S, Zweegman, S, Sackmann, F, Kerguelen Fuentes, A, Hernandez-Maraver, D, Doehner, K, Harrison, C N, Radia, D, Muxi, P, Besses, C, Cervantes, F, Johansson, P L, Andreasson, B, Rambaldi, A, Barbui, T, Bonatz, K, Reiter, A, Boyer, F, Etienne, G, Ianotto, J-C, Ranta, D, Roy, L, Cahn, J-Y, Maldonado, N, Barosi, G, Ferrari, M L, Gale, R P, Birgegard, G, Xu, Z, Zhang, Y, Sun, X, Xu, J, Zhang, P, te Boekhorst, P A W, Commandeur, S, Schouten, H, Pahl, H L, Griesshammer, M, Stegelmann, F, Lehmann, T, Senyak, Z, Vannucchi, A M, Passamonti, F, Samuelsson, J & Mesa, R A 2016, ' Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease ', Journal of Clinical Oncology, vol. 34, no. 2, pp. 151-+ . https://doi.org/10.1200/JCO.2015.62.9337
Journal of Clinical Oncology, 34(2), 151-+. American Society of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2016, 34 (2), pp.151-9. ⟨10.1200/JCO.2015.62.9337⟩
Purpose Polycythemia vera (PV) is a myeloproliferative neoplasm (MPN) associated with disabling symptoms and a heightened risk of life-threatening complications. Recent studies have demonstrated the effectiveness of JAK inhibitor therapy in patients
Autor:
Francesco Passamonti, Pablo J. Muxi, Robyn M. Scherber, Zhijian Xiao, Alessandro M. Vannucchi, Stefanie Slot, Tiziano Barbui, Gunnar Birgegård, Ana Kerguelen Fuentes, D. Radia, Federico Sackmann, Holly L. Geyer, Francisco Cervantes, Ruben A. Mesa, Bjorn Andreasson, Peter L. Johansson, Jan Samuelsson, Konstanze Döhner, Claire N. Harrison, Jean-Jacques Kiladjian, Alessandro Rambaldi, Dolores Hernández-Maraver, Amylou C. Dueck, Sonja Zweegman, Carlos Besses
Publikováno v:
Blood, 123(24), 3803-3810. American Society of Hematology
Geyer, H L, Scherber, R M, Dueck, A C, Kiladjian, J J, Xiao, Z J, Slot, S, Zweegman, S, Sackmann, F, Fuentes, A K, Hernandez-Maraver, D, Dohner, K, Harrison, C N, Radia, D, Muxi, P, Besses, C, Cervantes, F, Johansson, P L, Andreasson, B, Rambaldi, A, Barbui, T, Vannucchi, A M, Passamonti, F, Samuelsson, J, Birgegard, G & Mesa, R A 2014, ' Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients ', Blood, vol. 123, no. 24, pp. 3803-3810 . https://doi.org/10.1182/blood-2013-09-527903
Geyer, H L, Scherber, R M, Dueck, A C, Kiladjian, J J, Xiao, Z J, Slot, S, Zweegman, S, Sackmann, F, Fuentes, A K, Hernandez-Maraver, D, Dohner, K, Harrison, C N, Radia, D, Muxi, P, Besses, C, Cervantes, F, Johansson, P L, Andreasson, B, Rambaldi, A, Barbui, T, Vannucchi, A M, Passamonti, F, Samuelsson, J, Birgegard, G & Mesa, R A 2014, ' Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients ', Blood, vol. 123, no. 24, pp. 3803-3810 . https://doi.org/10.1182/blood-2013-09-527903
Symptom burden in myeloproliferative neoplasms (MPNs) is heterogeneous even among patients within the same MPN diagnosis. Using cluster analysis from prospectively gathered symptom burden data in 1470 international patients with essential thrombocyth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d453bed5897d9ef666f789f4d5d9213b
https://research.vumc.nl/en/publications/0f9f4a35-6961-43ef-86fc-916312d3646e
https://research.vumc.nl/en/publications/0f9f4a35-6961-43ef-86fc-916312d3646e
Autor:
Mohan Mahalakshmi, Mallika Sekhar, Mary Frances McMullin, Bjorn Andreasson, Peter L. Johansson, Gunnar Birgegård, Deepti Radia, Federico Sackmann, Ana Kerguelen Fuentes, Nan Zhang, Frances Wadelin, Nigel Sargant, Wunna Swe, John Hudson, Constantine S. Tam, Ruben A. Mesa, Satareh Shekouhi, Victoria Drew, Robyn M. Scherber, Alessandro M. Vannucchi, Jan Jacques Michiels, Robert N Lown, Jean-Loup Demory, Heidi E. Kosiorek, Daniel M Jennings, David M. Ross, Jonathan O. Cullis, Christen Lykkegaard Andersen, Veena Fauble, Mari Frances Kilner, Allison H. Scotch, Amylou C. Dueck, Joanne Ewing, Elisabeth Ejerblad, Holly L. Geyer, Paul Moreton, Catherine Cargo
Publikováno v:
Blood. 128:5479-5479
Background: Myeloproliferative neoplasms (MPN) including polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF) are clonal hemopathies characterized by burdensome symptom profiles and impaired quality of life. Few studies have
Autor:
Norman Maldonado, Deepti Radia, Tiziano Barbui, Dana Ranta, Giovanni Barosi, Maria Grazia Ferrari, Carlos Besses, Federico Sackmann, Andreas Reiter, Ruben A. Mesa, Lydia Roy, Xiujuan Sun, Suzan Commandeur, Ana Kerguelen Fuentes, Peter A. W. te Boekhorst, Bjorn Andreasson, Robyn M. Scherber, Peter L. Johansson, Jean-Jacques Kiladjian, Karen Bonatz, Francesco Passamonti, Stefanie Slot, Alessandro Rambaldi, Françoise Boyer, Jean Christophe Ianotto, Heidi E. Kosiorek, Frank Stegelmann, Sonja Zweegman, Martin Griesshammer, Claire N. Harrison, Konstanze Doehner, Gabriel Etienne, Jan Samuelsson, Jean-Yves Cahn, Francisco Cervantes, Heike L. Pahl, Zefeng Xu, Keith Cannon, Junqing Xu, Peihong Zhang, Alessandro M. Vannucchi, Dolores Hernández-Maraver, Amylou C. Dueck, Holly L. Geyer, Thomas Lehmann, Pablo J. Muxi, Harry C. Schouten
Publikováno v:
Blood. 128:5463-5463
BACKGROUND: Symptom burden in essential thrombocythemia (ET) and polycythemia vera (PV) is severe even among individuals with low risk disease (Blood 2012. 12;123(24):3803-10). New therapies exist which alleviate the severe symptom burden and reduce